Trials
Search / Trial NCT06429215

REducing the Risk of COgnitive DEcline ad Dementia in Patients With Subjective Cognitive Decline Through an Immersive Virtual Reality and Telemedicine-based Multi-component Intervention: the SCD-ReCODED Study

Launched by I.R.C.C.S. FONDAZIONE SANTA LUCIA · May 20, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

Subjective Cognitive Decline Multi Component Training Non Pharmacological Intervention Virtual Reality Telemedicine

ClinConnect Summary

The SCD-ReCODED Study is a clinical trial aimed at helping older adults who feel they are experiencing memory or thinking problems, known as subjective cognitive decline (SCD). These individuals are at a higher risk of developing dementia in the future. The trial is testing a new program that uses immersive virtual reality (IVR) and telemedicine to provide cognitive training and lifestyle education. The goal is to see if this approach can help prevent further cognitive decline and improve overall well-being.

To participate in the study, individuals should feel that their thinking has declined compared to five years ago, but they should not have any significant memory issues detected by a doctor. Excluded from the trial are those with serious mental health conditions or unstable medical issues. Participants will take part in 20 sessions at home, spread over five weeks, where they will engage in activities designed to boost their thinking skills and learn about healthy living. Throughout the study, researchers will assess changes in participants' cognitive abilities, mood, and overall quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-perceived decline in cognition compared to five years ago
  • Lack of objective cognitive impairment.
  • Exclusion Criteria:
  • Clinically significant depression and anxiety;
  • Psychiatric disorders;
  • Unstable medical conditions.
  • Severe visual, auditory, verbal or physical impairments interfere with communication, command compliance, and strategy execution
  • Dizziness or epilepsy history;

About I.R.C.C.S. Fondazione Santa Lucia

i.r.c.c.s. Fondazione Santa Lucia is a leading Italian research institute dedicated to advancing scientific knowledge in the fields of neuroscience, rehabilitation, and health sciences. As a clinical trial sponsor, the foundation is committed to conducting high-quality research aimed at improving patient outcomes and enhancing the understanding of neurological disorders. With a multidisciplinary team of experts and state-of-the-art facilities, Fondazione Santa Lucia fosters collaboration between researchers, healthcare professionals, and industry partners to translate innovative findings into effective therapeutic strategies and interventions.

Locations

Rome, Lazio, Italy

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0